EXHIBIT 99.2 LC ACQUISITION CORP. SUBSCRIPTION AGREEMENT LC Acquisition Corp. c/o Union Square Partners, Ltd. 200 Park Avenue South New York, New York 10003 Ladies and Gentlemen: The undersigned subscriber or subscribers (hereinafter the "Investor")...Subscription Agreement • December 21st, 2001 • Mangano Ross J • Real estate dealers (for their own account) • California
EXHIBIT 99.6 JOINT FILING AGREEMENT This JOINT FILING AGREEMENT, dated as of December 20, 2001, by and among each of the persons named on the signature pages hereto. WHEREAS, Ross J. Mangano, Troon & Co., an Indiana general partnership and BANKONE...Joint Filing Agreement • December 21st, 2001 • Mangano Ross J • Real estate dealers (for their own account)
EXHIBIT 99.3 LC ACQUISITION CORP. SUBSCRIPTION AGREEMENT LC Acquisition Corp. c/o Union Square Partners, Ltd. 200 Park Avenue South New York, New York 10003 Ladies and Gentlemen: The undersigned subscriber or subscribers (hereinafter the "Investor")...Subscription Agreement • December 21st, 2001 • Mangano Ross J • Real estate dealers (for their own account) • California
Exhibit 99.1 EXHIBIT 99.1 Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 3 to Schedule 13G need be filed with respect to...Mangano Ross J • February 13th, 2004 • Biological products, (no disgnostic substances)
ContractMangano Ross J • February 11th, 2010 • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 9 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.
ContractMangano Ross J • February 3rd, 2009 • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 8 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.
ContractMangano Ross J • February 14th, 2008 • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 7 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.
ContractMangano Ross J • February 5th, 2007 • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Amendment No. 6 to Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of common stock of BioSante Pharmaceuticals, Inc.
